Hematologic Malignancies , Table of Contents
Writer and Curator: Larry H. Bernstein, MD, FCAP
Hematologic Malignancies
Not excluding lymphomas [solid tumors]
The following series of articles are discussions of current identifications, classification, and treatments of leukemias, myelodysplastic syndromes and myelomas.
2.4 Hematological Malignancies
2.4.1 Ontogenesis of blood elements
Erythropoiesis
White blood cell series: myelopoiesis
Thrombocytogenesis
2.4.2 Classification of hematopoietic cancers
Primary Classification
Acute leukemias
Myelodysplastic syndromes
Acute myeloid leukemia
Acute lymphoblastic leukemia
Myeloproliferative Disorders
Chronic myeloproliferative disorders
Chronic myelogenous leukemia and related disorders
Myelofibrosis, including chronic idiopathic
Polycythemia, including polycythemia rubra vera
Thrombocytosis, including essential thrombocythemia
Chronic lymphoid leukemia and other lymphoid leukemias
Lymphomas
Non-Hodgkin Lymphoma
Hodgkin lymphoma
Lymphoproliferative disorders associated with immunodeficiency
Plasma Cell dyscrasias
Mast cell disease and Histiocytic neoplasms
Secondary Classification
Nuance – PathologyOutlines
2.4.3 Diagnostics
Computer-aided diagnostics
Back-to-Front Design
Realtime Clinical Expert Support
Regression: A richly textured method for comparison and classification of predictor variables
Converting Hematology Based Data into an Inferential Interpretation
A model for Thalassemia Screening using Hematology Measurements
Measurement of granulocyte maturation may improve the early diagnosis of the septic state.
The automated malnutrition assessment.
Molecular Diagnostics
Genomic Analysis of Hematological Malignancies
Next-generation sequencing in hematologic malignancies: what will be the dividends?
Leveraging cancer genome information in hematologic malignancies.
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
Genomic approaches to hematologic malignancies
2.4.4 Treatment of hematopoietic cancers
2.4.4.1 Treatments for leukemia by type
2.4.4..2 Acute lymphocytic leukemias
2.4..4.3 Treatment of Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
Leukemias Treatment & Management
Treatments and drugs
2.4.5 Acute Myeloid Leukemia
New treatment approaches in acute myeloid leukemia: review of recent clinical studies
Novel approaches to the treatment of acute myeloid leukemia.
Current treatment of acute myeloid leukemia
Adult Acute Myeloid Leukemia Treatment (PDQ®)
2.4.6 Treatment for CML
Chronic Myelogenous Leukemia Treatment (PDQ®)
What`s new in chronic myeloid leukemia research and treatment?
4.2.7 Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Results from the Phase 3 Resonate™ Trial
Typical treatment of chronic lymphocytic leukemia
4.2.8 Lymphoma treatment
4.2.8.1 Overview
4.2.8.2 Chemotherapy
………………………………..
Chapter 6
Total body irradiation (TBI)
Bone marrow (BM) transplantation
Autologous stem cell transplantation
Hematopoietic stem cell transplantation
Supportive Therapies
Blood transfusions
Erythropoietin
G-CSF (granulocyte-colony stimulating factor)
Plasma exchange (plasmapheresis)
Platelet transfusions
Steroids
Leave a Reply